Ce. Spivak et Cl. Beglan, Kinetics of recovery from opioids at wild-type and mutant mu opioid receptors expressed in Xenopus oocytes, SYNAPSE, 38(3), 2000, pp. 254-260
To investigate a previous observation that classical antagonists behave as
agonists at mutant H297N and H297Q mu opioid receptors, we compared the kin
etics of recovery from opioids at wild-type and mutant mu receptors express
ed in voltage-clamped Xenopus oocytes. The cDNA for the potassium channel G
IRK1 was coinjected into the oocytes with that of the mu receptors to trans
duce agonist binding into a coupled electrophysiological response. The kine
tics of recovery were estimated by brief test pulses of the agonist normorp
hine given at a frequency of 0.67 or 1 per min. After treatment with a vari
ety of agonists, the receptors recovered from desensitization at rates that
depended on the agonist, but there was little difference between mutant an
d wild-type receptors. Antagonists, however, induced agonist-like currents
and demonstrated faster recovery at the mutant receptors. These results sug
gest that His-297 may comprise part of an antagonist subsite. This conclusi
on, when coupled with the steric theory that intrinsic activity depends on
independent binary equilibration of a drug between agonist and antagonist s
ubsites, could unify the paired observations that antagonists become agonis
ts and recover faster at the mutant than at the wild-type receptors. Publis
hed 2000 Wiley-Liss, Inc.dagger